A detailed history of Clear Investment Research, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clear Investment Research, LLC holds 253 shares of ABBV stock, worth $45,337. This represents 0.06% of its overall portfolio holdings.

Number of Shares
253
Previous 253 -0.0%
Holding current value
$45,337
Previous $43,000 13.95%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $309 - $361
2 Added 0.8%
253 $43,000
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $9,429 - $10,743
-59 Reduced 19.03%
251 $45,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $42,656 - $48,040
310 New
310 $48,000
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $721 - $902
-10 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $188 - $227
3 Added 42.86%
10 $1,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $622 - $691
7 New
7 $1,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clear Investment Research, LLC Portfolio

Follow Clear Investment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Investment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Investment Research, LLC with notifications on news.